Churg-Strauss syndrome associated with AA amyloidosis: a case report
Mouna Maamar, Zoubida Tazi-Mezalek, Hicham Harmouche, Zitouna El Hamany, Mohammed Adnaoui, Mohammed Aouni
The Pan African Medical Journal. 2012;12:30. doi:10.11604/pamj.2012.12.30.1616

Innovations in Measles Elimination Innovations in Measles Elimination
"Better health through knowledge sharing and information dissemination "

Case report

Churg-Strauss syndrome associated with AA amyloidosis: a case report

Cite this: The Pan African Medical Journal. 2012;12:30. doi:10.11604/pamj.2012.12.30.1616

Received: 26/03/2012 - Accepted: 09/06/2012 - Published: 11/06/2012

Key words: Churg-Strauss syndrome, amyloidosis, vasculitis, purpura

© Mouna Maamar et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Available online at:

Corresponding author: Mouna Maamar, Department of Internal Medicine Ibn Sina Hospital Rabat, Morocco (

Churg-Strauss syndrome associated with AA amyloidosis: a case report


Mouna Maamar1,&, Zoubida Tazi-Mezalek1, Hicham Harmouche1, Zitouna El Hamany2, Mohammed Adnaoui1, Mohammed Aouni1


1Department of Internal Medicine Ibn Sina Hospital Rabat Morocco, 2Department of Nephrology Ibn Sina Hospital Rabat Morocco



&Corresponding author
Mouna Maamar, Department of Internal Medicine Ibn Sina Hospital, Rabat, Morocco




Churg Strauss syndrome is a rare systemic and pulmonary vasculitis defined by the association of severe asthma, hypereosinophilia of the blood and tissues and vasculitis [1]. We report an exceptional case of Churg-Strauss syndrome associated with renal amyloidosis AA.



Patient and observation

A 65-year old Moroccan woman was hospitalized for polyarthralgia and frontal headache. She had a past medical history of asthma for 10 years and was operated for hydatid cyst of the liver in 1998. She has no history of tuberculosis, no chronic abdominal pain.


On physical examination, blood pressure was 140/70 mmHg and the heart rate 70/min. She has no fever and the peripheral pulses were all present. We noted an infiltrated purpura in the lower extremities and a wheezing in the pulmonary fields. She has areflexia and sensory involvement in the lower limbs.


Hemoglobin was at 7.5 g/dl, MCV 80 fl, Reticulocyte count at 47.10X3/mm3, platelet count at 730 000/ µL (Normal 150 - 450 000) and white blood cell count 10000/ µL with neutrophil 4300, lymphocytes at 3600/ µL and eosinophil 1150/ µL (normal 100-500/ µL). Erythrocyt sedimentation rate was 130 mm first hour, C-reactive protein 38 mg/l (range < 6 mg/l), fibrinogen 6 g/l (2-4 g/l) and serum protein electrophoresis showed a polyclonal IgG 24 g/l (range 9-13 g/l) with normal immunofixation. There was renal failure with urea 3 mmol/l (normal 3 – 8.5), creatinemia 160 µmol/l (normal 45 -100) and creatinine clearance at 30 ml/min (Cockcroft formula).


Urinalysis showed a microscopic haematuria at 20 000 cell/mm3 and proteinuria at 2.5g/24Hr. Cryoglobulinemia was negative, p-ANCA were present. Electromyography showed an axonal polyneuropathy of the 4 limbs. Skin biopsy revealed leukocytoclastic vasculitis with extra-vascular eosinophil. Thorax CT showed pulmonary infiltrates changes. Brain CT, temporal artery biopsy and ocular examination were all normal. Renal biopsy did not reveal vasculitis or inflammatory process, but an important type AA amyloid deposit. Salivary biopsy also showed AA amyloid deposit. She has no Familial Mediterranean fever, no history of tuberculosis or other chronic infections.


The diagnosis of Churg Strauss associated with AA amyloidosis was established with five criteria of the American College of Rheumatology (ACR).


Steroids were administered at a pulse of methyprednisolone 1g/day for 3 days followed by oral prednisone at 1 mg/kg/day for 4 weeks and progressively tapered. The patient was also treated with captopril. The clinical and biological response was obtained with disappearance of pain; eosinophil count decrease to 300/µL and negativity of proteinuria. At 26 months follow-up proteinuria remained negative.




AA amyloidosis is a classical complication of longstanding chronic inflammatory conditions such as rheumatoid arthritis, ankylosing spondylitis, chronic infections such as tuberculosis, osteomyelitis or during periodic fever syndrome such as Familial Mediterranean fever [2].


In the largest prospective series of 374 AA amyloidosis, the most frequent underlying disorder was rheumatoid arthritis (33%) and juvenile idiopathic arthritis (17%) [3]. Vasculitis was reported in only four patients [3]. Among vasculitis, Behcet’s disease is the most frequent cause of amyloidosis [4].


In our patient, we excluded the most frequent causes of amyloidosis such as tuberculosis, rheumatoid arthritis and she has no Familial Mediterranean fever. To our knowledge this is the first report of renal amyloidosis associated with the Churg-Strauss syndrome. Only one other case of Churg-Strauss syndrome with localized conjonctival amyloidosis has been reported in the literature as an abstract [5]. This association is exceptional because inflammatory process is rare in Churg-Strauss syndrome. This disease is characterized by a strong Th2 type immune response with production of Interleukin 13, 14 and 15 cytokines [6]. Interleukin-5 is one of the key inducers of eosinophilia [7]. Thus, it is very important to first exclude the most frequent causes of renal amyloidosis.




Churg-Strauss syndrome is a rare vasculitis wich exceptionally complicated by AA amyloidosis. Renal involvement is uncommon in this vasculitis and should encourage realizing renal biopsy.



Competing interests

The authors declare no competing interests.



Author’s contributions

All the authors have contributed to this work and have read and approved the final version of the manuscript.




  1. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome - Clinical study and long-term follow-up of 96 patients. Medicine. 1999; 78: 26-37. This article on PubMed

  2. Petterson T, Kontinnen YT. Amyloidosis recent developments. Semin Arthritis Rheum. 2010;39: 356-68. This article on PubMed

  3. Lachmann JH, Goodman H, Gilbertson JA, Gallimore R, Sabin C, Gillmore D. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007; 356: 2361-71. This article on PubMed

  4. Ounissi M, Ben Abdelghani K, Gargueh T, Turki S, Goucha R, Abderrahim E, Ben Hamida F, Ben Maiz H, Kheder A. Renal involvement in Behcet’s disease. Tunis Med. 2010;88: 404-8. This article on PubMed

  5. Meisler DM, Stock EL, Wertz RD, Khadem M, Chaudhuri B, O'Grady RB. Conjunctival inflammation and amyloidosis in allergic granulomatosis and angiitis (Churg-Strauss syndrome). Am J Ophthalmol. 1981 Feb;91(2):216-9. This article on PubMed

  6. Hellmich B, Ehlers S, Csernok E, Gross WL. Update on the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S69-77. This article on PubMed

  7. Zwerina J, Axmann R, Jatzwauk M, Sahinbegovic E, Polzer K, Schett G. Pathogenesis of Churg-Strauss syndrome: recent insights. Autoimmunity. 2009 May;42(4):376-9. This article on PubMed













The Pan African Medical Journal articles are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 33 (May - August 2019)

Article tools

PDF (306 Kb)
Contact the corresponding author
Download to Citation Manager
Reference Manager


Churg-Strauss syndrome

Rate this article


PAMJ is a member of the Committee on Publication Ethics
PAMJ Authors services
Next abstract

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2019 - Pan African Medical Journal. All rights reserved